The escalating tuberculosis crisis in central and South American prisons.


Journal

Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R

Informations de publication

Date de publication:
24 04 2021
Historique:
received: 15 06 2020
revised: 26 10 2020
accepted: 25 11 2020
pubmed: 12 4 2021
medline: 4 1 2022
entrez: 11 4 2021
Statut: ppublish

Résumé

In the past decade, tuberculosis incidence has declined in much of the world, but has risen in central and South America. It is not yet clear what is driving this reversal of progress in tuberculosis control. Since 2000, the incarcerated population in central and South America has grown by 206%, the greatest increase in the world. Over the same period, notified tuberculosis cases among the incarcerated population (hereinafter termed persons deprived of their liberty [PDL], following the Inter-American Commission on Human Rights) have risen by 269%. In both central and South America, the rise of disease among PDL more than offsets tuberculosis control gains in the general population. Tuberculosis is increasingly concentrated among PDL; currently, 11% of all notified tuberculosis cases in central and South America occur among PDL who comprise less than 1% of the population. The extraordinarily high risk of acquiring tuberculosis within prisons creates a health and human rights crisis for PDL that also undermines wider tuberculosis control efforts. Controlling tuberculosis in this region will require countries to take urgent measures to prioritise the health of PDL.

Identifiants

pubmed: 33838724
pii: S0140-6736(20)32578-2
doi: 10.1016/S0140-6736(20)32578-2
pmc: PMC9393884
mid: NIHMS1825684
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1591-1596

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI130058
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI052073
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests RAL-O serves as Tuberculosis Prevention, Control and Elimination Advisor at the HIV, Hepatitis, Tuberculosis and Sexually Transmitted Infections Unit of the PAHO. MAE is Director of the Department of Communicable Diseases and Environmental Determinants of Health at the PAHO. All other authors declare no competing interests.

Références

Rev Panam Salud Publica. 2016 Jan;39(1):38-43
pubmed: 27754539
Rev Bras Epidemiol. 2011 Sep;14(3):486-94
pubmed: 22069016
Lancet. 2016 Sep 10;388(10049):1089-1102
pubmed: 27427453
Cad Saude Publica. 2015 Jun;31(6):1127-30
pubmed: 26200361
N Engl J Med. 2020 May 28;382(22):2075-2077
pubmed: 32240582
S Afr Med J. 2011 Nov 01;101(11):809-13
pubmed: 22272961
Lancet Public Health. 2021 May;6(5):e300-e308
pubmed: 33765455
Lancet Infect Dis. 2001 Oct;1(3):199-202
pubmed: 11871496
Am J Trop Med Hyg. 2015 Oct;93(4):739-46
pubmed: 26195459
Int J Tuberc Lung Dis. 2014 Nov;18(11):1285-91
pubmed: 25299859
Clin Infect Dis. 2021 Mar 1;72(5):771-777
pubmed: 32064514
Lancet Infect Dis. 2020 Aug;20(8):929-942
pubmed: 32334658
BMC Med. 2018 Aug 3;16(1):122
pubmed: 30071850
Sci Rep. 2018 Jan 17;8(1):997
pubmed: 29343733
Lancet. 2011 Mar 12;377(9769):956-65
pubmed: 21093904
Lancet. 2016 Sep 17;388(10050):1202-14
pubmed: 27427457
Emerg Infect Dis. 2012 Nov;18(11):1802-10
pubmed: 23092584
PLoS Med. 2019 Jan 24;16(1):e1002737
pubmed: 30677013
Emerg Infect Dis. 2015 Mar;21(3):452-5
pubmed: 25642998
Lancet Psychiatry. 2016 Sep;3(9):871-81
pubmed: 27426440

Auteurs

Katharine S Walter (KS)

Division of Infectious Diseases & Geographic Medicine, School of Medicine, Stanford University, Stanford, CA, USA. Electronic address: kwalter@stanford.edu.

Leonardo Martinez (L)

Division of Infectious Diseases & Geographic Medicine, School of Medicine, Stanford University, Stanford, CA, USA.

Denise Arakaki-Sanchez (D)

Ministry of Health of Brazil, Brasília, Brazil.

Victor G Sequera (VG)

ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Department of Health Surveillance, Asunción, Paraguay.

G Estigarribia Sanabria (G)

Instituto Regional de Investigación en Salud, Universidad Nacional de Caaguazú, Coronel Oviedo, Paraguay.

Ted Cohen (T)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.

Albert I Ko (AI)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA; Oswaldo Cruz Foundation, Salvador, Brazil.

Alberto L García-Basteiro (AL)

ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique.

Zulma Vanessa Rueda (ZV)

Universidad Pontificia Bolivariana, Medellín, Colombia; University of Manitoba, Winnipeg, Canada.

Rafael A López-Olarte (RA)

Pan American Health Organization, Communicable Diseases and Environmental Determinants of Health, Washington, DC, USA.

Marcos A Espinal (MA)

Pan American Health Organization, Communicable Diseases and Environmental Determinants of Health, Washington, DC, USA.

Julio Croda (J)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA; School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil; Oswaldo Cruz Foundation, Mato Grosso do Sul, Brazil.

Jason R Andrews (JR)

Division of Infectious Diseases & Geographic Medicine, School of Medicine, Stanford University, Stanford, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH